About 8 results found for searched term "87-67-2" (0.055 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M1828 | Tandutinib | FLT3 |
| MLN518, CT53518 | ||
| Tandutinib (MLN518, CT53518) is an orally active multitargeted tyrosine kinase inhibitor of FLT3 (IC50 = 0.22 μM), and it also inhibits c-Kit and PDGFR with IC50 values of 0.17 μM and 0.20 μM, respectively. Tandutinib has the ability to cross the blood-brain barrier. | ||
| M5734 | Lesinurad | URAT1 |
| RDEA 594, RDEA-594, RDEA594 | ||
| Lesinurad is a URAT1 and OAT inhibitor, is determined to be a substrate for the kidney transporters OAT1 and OAT3 with Km values of 0.85 and 2 µM, respectively. | ||
| M7696 | Choline bitartrate | Others |
| Acyl group acceptor. | ||
| M10245 | Pemafibrate | PPAR |
| K-877; (R)-K 13675; CS-2768 | ||
| Pemafibrate is a potent and highly specific PPARα agonist, with EC50s of 1 nM, 1.10 μM and 1.58 μM for h-PPARα, h-PPARγ and h-PPARδ, respectively. | ||
| M22389 | c-Fms inhibitor 2 | Others |
| c-Fms inhibitor 2 | ||
| M28633 | Ubretid | AChR/AChE |
| Distigmine dibromide | ||
| Ubretid is a potent inhibitor of plasma cholinesterase. Ubretid therefore delays the hydrolysis of suxamethonium and prolongs its action, similar to the effects shown by other anticholinesterase agents, such as pyridostigmine and donepezil. Ubretid has the potential for the research of urinary retention prolongs the effect of suxamethonium. Ubretid is commonly prescribed for the research of myasthenia gravis and for difficulty in emptying the bladder. | ||
| M52764 | α-Conotoxin RgIA | AChR/AChE |
| α-Conotoxin RgIA (α-RgIA) is a specific α9α10 nAChR antagonist. | ||
| M57968 | Compound STL565749 | Others |
| Compound STL565749 | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
